Patients With Advanced Lung Cancer Prioritize Social, Relational Goals Above Treatment Outcomes
“The goals of people with advanced lung cancer undergoing first-line therapy tend to be focused on relationships and living well, according to a new study. This report also shows that most people surveyed viewed their goals as attainable.”

Nearly 90% of significant incidental findings on lung cancer screenings are considered reportable
“New data derived from the National Lung Screening Trial reveal that more than 30% of low dose computed tomography (LDCT) lung cancer screenings contain significant incidental findings that warrant radiologists’ attention.”

Enrollment Open for a Trial of Novel Drug-Chemo Combo for Lung Cancer
“The phase 3 HARMONi clinical trial recently kicked off, evaluating the novel drug ivonescimab in combination with chemotherapy for patients with EGFR-mutant, locally advanced or metastatic non-squamous non-small cell lung cancer who experienced disease progression after treatment with a third-generation tyrosine kinase inhibitor (TKI) drug, such as Tagrisso (osimertinib).”

Surgery beats targeted radiation for patients battling early stage lung cancer
“More patients are choosing radiation therapy over surgery to treat their early-stage lung cancer, but a new study argues they might be making a mistake.”

Cemiplimab + Chemotherapy Aids Quality of Life With Lung Cancer
“WEDNESDAY, May 10, 2023 (HealthDay News) — Cemiplimab plus chemotherapy results in significant overall improvement in pain symptoms and delayed deterioration in cancer-related and lung cancer-specific symptoms and functions, according to a study published online May 8 in Cancer.”

Addressing lung cancer health disparities, by Dr. Robert A. Winn
“The cancer field has made incredible progress in “molecules to medicine” – finding new ways to target and treat cancer and developing innovative treatments such as immunotherapies. But these advances alone are not going to solve persistent disparities in lung cancer, which disproportionately impact Black Americans.”

Artificial intelligence and robotics help Atrium Health Wake Forest Baptist physicians better predict and diagnose lung cancer
“A new artificial intelligence (AI) tool is helping physicians at Atrium Health Wake Forest Baptist better predict and diagnose lung cancer in patients.”

Lung cancer flash news: chemokine biomarker and immuno-chemo for a better life quality
“Innovational cancer treatments such as immunotherapy are offering new hope to patients.”

Drug combination can prolong survival and improve quality of life in patients with advanced lung cancer
“A recent clinical trial showed that the drug combination of cemiplimab plus platinum chemotherapy can prolong survival in patients with advanced lung cancer when compared with placebo plus platinum chemotherapy. Now an analysis published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, indicates that cemiplimab plus platinum chemotherapy also affects quality of life compared to chemotherapy alone.”